Moments in
Dual Anti-Platelet Therapy

CRT 2016 Coronary - Antiplatelet Controversies for ACS: How Will They Impact Our Practice?
Conference
Antiplatelet Controversies for ACS: 'How Will They Impact Our Practice?' at CRT 2016
CRT 2016 Coronary - Antiplatelet Responsiveness, Genetics, Genomics and Drug-to-Drug Interactions: The Great Debate
Conference
Session on Antiplatelet Responsiveness, Genetics, Genomics and Drug-to-Drug Interactions: The Great Debate at CRT 2016
CRT 2016 Coronary - CTO Academy - Best Abstracts
Conference
CTO Academy - Best Abstracts at CRT 2016
CRT 2016 Coronary - Acute MI Management
Conference
Acute MI Management at CRT 2016
CRT 2015 Coronary - Antiplatelet Controversy For ACS: How will this iMPACT our Practice?
Conference
A session on Antiplatelet Controversy For ACS and How this will iMPACT a Practice, from CRT 2015.
CRT 2015 Coronary - Antiplatelet Responsiveness, Genetics, Genomics and Drug-to-Drug Interactions: The Great Debate
Conference
A session on Antiplatelet Responsiveness, Genetics, Genomics and Drug-to-Drug Interactions: The Great Debate at CRT 2015
CRT 2015 Coronary - Acute MI Management
Conference
A session on Acute MI Management from CRT 2015
Novel Oral Anti-Coagulants (NOACs): Hot Topics & Current Issues
Roundtable
On 12 November 2014, Radcliffe Cardiology, in association with Arrhythmia & Electrophysiology Review (AER) journal, held a roundtable discussion in London, UK. The discussion held between an expert...
Platelet Function Testing
Roundtable
During ESC 2013 (NL), Radcliffe Cardiology, in association with the Interventional Cardiology Review journal, filmed a roundtable discussion entitled 'Balancing the Efficacy and Safety of Antiplate...
CRT 2015 - Satellite Symposium: Novel Therapeutic Pathways in the Secondary Prevention of Atherothrombotic Events in AMI
Conference
A session on Novel Therapeutic Pathways in the Secondary Prevention of Atherothrombotic Events in AMI from CRT 2015
Supported By
CRT 2016 Technology & Innovation - DES Thrombosis Restenosis and DAPT Duration
Conference
DES Thrombosis Restenosis and DAPT Duration at CRT 2016
CRT 2016 Technology & Innovation - Evaluating DES for High-risk DAPT Patients
Conference
A session Evaluating DES for High-risk DAPT Patients from CRT 2016
CRT 2016 Endovascular - Optimization of Anticoagulation for STEMI Therapy
Conference
A session on Optimization of Anticoagulation for STEMI Therapy from CRT 2016
CRT 2015 Technology & Innovation - Hot Topic II: Duration of DAPT Post DAPT Trial
Conference
Hot Topic II: Duration of DAPT Post DAPT Trial from CRT 2015
CRT 2015 Technology & Innovation - DES Thrombosis Restenosis and DAPT Duration
Conference
A session on DES Thrombosis Restenosis and DAPT Duration from CRT 2015
CRT 2015 Endovascular - Optimization of Anticoagulation for STEMI Therapy
Conference
A session on Optimization of Anticoagulation for STEMI Therapy from CRT 2015
Supported By
CRT 2017: ACS & AMI Management - ACS Pharmacotherapy
Conference
A session on ACS Pharmacotherapy from CRT 2017
CRT 2017: ACS & AMI Management - STEMI 2017 Hot Topic: Multivessel Disease Treatment
Conference
CRT 2017 : Late Breaking Trials: Session I
Conference
Loading Simple Education